Compounds > deferoxamine

deferoxamine and busulfan

deferoxamine has been researched along with busulfan in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Bennett, M; Rodday, P; Vitale, JJ1
Barbanti, I; Capriotti, L; Dardanelli, C; Lucarelli, G; Politi, P; Salvadori, P1
Honetz, N; Klotz, H; Neumann, E1
Andreani, M; Gaziev, J; Lucarelli, G; Polchi, P; Sodani, P1
Boyraz, MS; Çağdaş, D; Güçer, Ş; Tezcan, İ; Uçkan Çetinkaya, D; Ünal, Ş1
Gao, J; Li, H; Li, Y; Liu, Z; Sun, F; Wang, X; Zhao, X1

Reviews

1 review(s) available for deferoxamine and busulfan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for deferoxamine and busulfan

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Delayed erythropoiesis in irradiated rats grafted with syngeneic marrow: effects of cytotoxic drugs and iron-deficiency anemia.
    Blood, 1976, Volume: 48, Issue:3

    Topics: Anemia, Hypochromic; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Deferoxamine; Erythropoiesis; Erythropoietin; Graft Rejection; Immunosuppression Therapy; Male; Radiation Chimera; Rats; Rats, Inbred Lew; Spleen; Time Factors; Transplantation, Isogeneic

1976
Liver iron stores before and after bone marrow transplantation for thalassemia.
    Progress in clinical and biological research, 1989, Volume: 309

    Topics: Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Deferoxamine; Ferritins; Graft vs Host Disease; Humans; Immunosuppressive Agents; Iron; Iron Chelating Agents; Liver; Thalassemia

1989
[Iron metabolism in polycythemia vera].
    Folia haematologica (Leipzig, Germany : 1928), 1971, Volume: 95, Issue:4

    Topics: Aged; Antineoplastic Agents; Bloodletting; Busulfan; Deferoxamine; Female; Hematocrit; Humans; Intestinal Absorption; Iron; Iron Isotopes; Male; Middle Aged; Polycythemia Vera; Serum Albumin, Radio-Iodinated

1971
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Annals of the New York Academy of Sciences, 2005, Volume: 1054

    Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical Protocols; Combined Modality Therapy; Comorbidity; Deferoxamine; Disease-Free Survival; Erythrocyte Transfusion; Erythropoietin; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hemosiderosis; Humans; Hydroxyurea; Immunosuppressive Agents; Iron Chelating Agents; Life Tables; Liver Cirrhosis; Male; Phlebotomy; Postoperative Complications; Survival Analysis; Thalassemia; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2005
Diagnosis: Melanoderma after Hematopoietic Stem Cell Transplantation.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2015, Volume: 32, Issue:4

    Topics: Antilymphocyte Serum; Busulfan; Deferoxamine; Diagnosis, Differential; Ecchymosis; Humans; Infant; Iron Overload; Male; Melanosis; Peripheral Blood Stem Cell Transplantation; Severe Combined Immunodeficiency; Transfusion Reaction; Transplantation Conditioning; Vidarabine

2015
Inhibition of ferroptosis attenuates busulfan-induced oligospermia in mice.
    Toxicology, 2020, Volume: 440

    Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Cation Transport Proteins; Cyclohexylamines; Cyclooxygenase 2; Deferoxamine; Ferroptosis; Male; Malondialdehyde; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Oligospermia; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Sperm Motility; Testis

2020